|
36MO Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer |
|
|
|
Titel: |
36MO Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer |
Auteur: |
Sacher, A. Le, X. Cornelissen, R. Shum, E. Suga, J. Socinski, M. Molina, J.R. Haura, E. Clarke, J. Bhat, G. Lebel, F. Garassino, M.C. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 32 () nr. S1 pagina's S15 |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|